|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 253/07 | |
| A61P 13/12 | |||
| A61P 9/04 | |||
| C07D 451/02 |
| (11) | Number of the document | 3135668 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782458.2 |
| Date of filing the European patent application | 2015-04-23 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/062440 |
| Date | 2015-04-23 |
| (87) | Number | WO 2015/163427 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 2014090754 | 2014-04-24 | JP |
| (72) |
USHIROGOCHI, Hideki, JP
SASAKI, Wataru, JP
ONDA, Yuichi, JP
SAKAKIBARA, Ryo, JP
AKAHOSHI, Fumihiko, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi,, Osaka 541-8505,
JP
|
| (54) | NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND |
| NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND |